Cargando…
The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report
This article describes the case of a 73-year-old patient with grade 3 immune checkpoint inhibitor (ICI)-induced enteritis. Five different immunosuppressive agents (glucocorticoids, high-dose infliximab, methotrexate, mycophenolate mofetil, and vedolizumab) were administered, however, with no clinica...
Autores principales: | Verhé, Manon, De Somer, Thomas, Defoort, Barbara, Vanderstraeten, Erik, Monsaert, Els, Bouderez, Vincent, Dias, Stefanie, Delombaerde, Danielle, Vulsteke, Christof, Van Steenkiste, Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294263/ https://www.ncbi.nlm.nih.gov/pubmed/37384210 http://dx.doi.org/10.1159/000530832 |
Ejemplares similares
-
Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy
por: Delombaerde, D., et al.
Publicado: (2021) -
Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study
por: Delombaerde, Danielle, et al.
Publicado: (2023) -
Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report
por: Delombaerde, Danielle, et al.
Publicado: (2022) -
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab
por: Alexander, James L, et al.
Publicado: (2021) -
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
por: Bergqvist, Viktoria, et al.
Publicado: (2017)